Document_and_Entity_Informatio
Document and Entity Information (USD $) | 9 Months Ended | |
Oct. 31, 2014 | Sep. 12, 2014 | |
Document And Entity Information | ||
Entity Registrant Name | MEDCAREERS GROUP, Inc. | |
Entity Central Index Key | 1438901 | |
Document Type | 10-Q | |
Document Period End Date | 31-Oct-14 | |
Amendment Flag | FALSE | |
Current Fiscal Year End Date | -30 | |
Is Entity a Well-known Seasoned Issuer? | No | |
Is Entity a Voluntary Filer? | No | |
Is Entity's Reporting Status Current? | Yes | |
Entity Filer Category | Smaller Reporting Company | |
Entity Public Float | $1,500,000 | |
Entity Common Stock, Shares Outstanding | 86,995,142 | |
Document Fiscal Period Focus | Q3 | |
Document Fiscal Year Focus | 2014 |
Balance_Sheets
Balance Sheets (USD $) | Oct. 31, 2014 | Jan. 31, 2014 |
Current assets: | ||
Cash and cash equivalents | $1,477 | $7,299 |
Other Current Assets | 400 | 400 |
Total Current Assets | 1,877 | 7,699 |
Property, Plant and Equipment: | ||
Equipment | 1,799 | 1,799 |
Less: Accumulated depreciation | -1,799 | -1,799 |
Total Fixed Assets | 0 | 0 |
TOTAL ASSETS | 1,877 | 7,699 |
Accounts Payable | 26,502 | 61,141 |
Accrued Expenses | 8,377 | 13,998 |
Accounts Payable - Related Parties | 0 | 246,808 |
Accrued Interest Payable | 186,256 | 173,444 |
Current portion of notes payable | 1,033,650 | 610,650 |
Total Current Liabilities | 1,254,785 | 1,106,041 |
Long Term Liabilities: | ||
Notes Payable | 1,033,650 | 610,650 |
Less: Current Potion | -1,033,650 | -610,650 |
Total Long Term Liabilities | 0 | 0 |
Total Liabilities | 1,254,785 | 1,106,041 |
Preferred Stock, $0.001 par value, 10,000,000 shares authorized, 1,000 and 1,000 shares issued and outstanding | 0 | 0 |
Common Stock, $0.001 par value, 850,000,000 shares authorized. 50125000 and 43,315,000 shares issued and outstanding | 83,210 | 65,715 |
Additional Paid In Capital | 5,022,564 | 4,679,251 |
Accumulated Deficit | -6,358,682 | -5,583,308 |
TOTAL STOCKHOLDERS' EQUITY (DEFICIT) | -1,252,908 | -1,098,342 |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $1,877 | $7,699 |
Balance_Sheets_Parenthetical
Balance Sheets (Parenthetical) (USD $) | Oct. 31, 2014 | Jan. 31, 2014 |
Statement of Financial Position [Abstract] | ||
Common Stock, par value | $0.00 | $0.00 |
Common Stock, shares issued | 10,000,000 | 10,000,000 |
Common Stock, shares outstanding | 0 | 0 |
Preferred Stock, par value | $0.00 | $0.00 |
Preferred Stock, shares issued | 850,000,000 | 350,000,000 |
Preferred Stock, shares outstanding | 83,210,142 | 65,715,368 |
Statements_of_Operations
Statements of Operations (USD $) | 3 Months Ended | 9 Months Ended | ||
Oct. 31, 2014 | Oct. 31, 2013 | Oct. 31, 2014 | Oct. 31, 2013 | |
Income Statement [Abstract] | ||||
Revenue | $7,970 | $3,185 | $19,758 | $11,405 |
Cost of Sales | 4,055 | 7,017 | 22,135 | 30,969 |
Gross Profit (Loss) | 3,915 | 3,832 | 2,377 | 19,564 |
Operating Expenses: | ||||
Depreciation and Amortization | 0 | 162,168 | 0 | 251,801 |
Selling and Marketing | 18,455 | 6,806 | 97,865 | 20,692 |
General and Administrative | 100,514 | 253,151 | 335,835 | 545,315 |
Total Operating Expenses | 118,969 | 422,125 | 433,700 | 817,808 |
Net Operating Loss | -115,054 | -425,937 | -436,077 | -837,372 |
Other Income (Expense): | ||||
Interest Expense | -30,577 | -22,731 | -79,297 | -60,748 |
Total Other Income (Expense) | -30,577 | -22,731 | -79,297 | -60,748 |
Net Loss | ($145,631) | ($448,688) | ($515,374) | ($898,120) |
Weighted Average Shares Outstanding, Basic and Diluted | 77,471,515 | 54,493,241 | 76,879,373 | 51,039,602 |
Basic and Diluted Earnings (Loss) per Share | $0 | ($0.01) | $0 | ($0.02) |
Shareholders_Equity
Shareholders Equity (USD $) | Common Stock | Additional Paid-In Capital | Retained Earnings / Accumulated Deficit | Total |
Begining balance, APIC at Jan. 31, 2013 | $3,997,996 | |||
Begining balance, stockholders' equity (deficit) at Jan. 31, 2013 | -4,755,621 | |||
Begining balance, amount at Jan. 31, 2013 | 50,126 | |||
Begining balance, shares outstanding at Jan. 31, 2013 | 50,125,528 | |||
Issuance of common stock for cash, shares | 249,000 | |||
Issuance of common stock for cash, amount | 249 | |||
Issuance of common stock, APIC | 24,651 | |||
Issuance of common stock for services, shares | 1,800,000 | |||
Issuance of common stock for services, amount | 1,800 | |||
Issuance of common stock for services, APIC | 150,200 | |||
Issuance of common stock for deferred fees, shares | 1,733,835 | |||
Issuance of common stock for deferred fees, amount | 1,733 | |||
Issuance of common stock for deferred fees, APIC | 171,601 | |||
Conversion of notes payable to common stock, shares | 11,807,505 | |||
Conversion of Notes Payable to Common Stock, amount | 11,808 | |||
Conversion of Notes Payable to Common Stock, APIC | 334,803 | |||
Rounding | -1 | 1 | ||
Net income (loss) | -1,087,688 | |||
Ending balance, APIC at Jan. 31, 2014 | 4,679,251 | |||
Stockholders' equity (deficit) at Jan. 31, 2014 | -5,843,308 | |||
Common stock, amount at Jan. 31, 2014 | 65,715 | 65,715 | ||
Common stock, shares outstanding at Jan. 31, 2014 | 65,715,368 | 0 | ||
Issuance of Common Stock for Accrued Expenses, shares | 6,536,160 | |||
Issuance of Common Stock for Accrued Expenses, Amount | 6,536 | |||
Issuance of Common Stock for Accrued Expenses, APIC | 320,272 | |||
Conversion of notes payable to common stock, shares | 10,958,614 | |||
Conversion of Notes Payable to Common Stock, amount | 10,959 | |||
Conversion of Notes Payable to Common Stock, APIC | 23,041 | |||
Net income (loss) | -515,374 | -515,374 | ||
Ending balance, APIC at Oct. 31, 2014 | 5,022,564 | -6,358,682 | ||
Common stock, amount at Oct. 31, 2014 | $83,210 | $83,210 | ||
Common stock, shares outstanding at Oct. 31, 2014 | 83,210,142 | 0 |
Statements_of_Cash_Flows
Statements of Cash Flows (USD $) | 9 Months Ended | |
Oct. 31, 2014 | Oct. 31, 2013 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | ||
Net Loss | ($515,374) | ($898,120) |
Adjustments to reconcile net loss to net cash used (provided) by operating activiites | ||
Amortization and Depreciation | 0 | 251,801 |
Common Stock Issued for Services | 0 | 140,000 |
Changes in assets and liabilities: | ||
Other Current Assets | 0 | -1,095 |
Accounts Payable | -34,639 | 51,099 |
Accrued Expenses | -621 | 61,892 |
Accrued Expenses - Related Party | 75,000 | 64,950 |
Accrued Interest Payable | 12,812 | 0 |
Net Cash Provided (Used) by Operating Acticities | -462,822 | -329,383 |
CASH FLOWS FROM INVESTING ACTIVITIES | ||
Purchase of Fixed Assets | 0 | 0 |
Net Cash Provided (Used) by Investing Activities | 0 | 0 |
CASH FLOWS FROM FINANCING ACTIVITIES | ||
Proceeds from Sale of Common Stock | 0 | 19,900 |
Proceeds from Notes Payable | 457,000 | 227,500 |
Conversion of Notes Payable to Common Stock | 34,000 | 0 |
Net Cash Provided by Financing Activities | 457,000 | 247,400 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUAVILENTS | -5,822 | -81,983 |
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD | 7,299 | 89,680 |
CASH AND CASH EQUIVALENTS AT END OF PERIOD | 1,477 | 7,697 |
SUPPLEMENTAL DISCLOSURES | ||
Cash Paid During the Year for Interest Expense | 3,000 | 4,575 |
Cash Paid During the Year for Taxes | 0 | 0 |
Issuance of Common Stock for Services | 0 | 140,000 |
Issuance of Common Stock for Payables | 326,808 | 0 |
Issuance of Common Stock for Deferred Fees | 0 | 173,333 |
Issuance of Common Stock for Debt | $34,000 | $0 |
Significant_Accounting_Policie
Significant Accounting Policies | 9 Months Ended |
Oct. 31, 2014 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies | NOTE 1 – NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES |
Nature of Activities, History and Organization – The Company was formed as RX Scripted, LLC on December 30, 2004 as a North Carolina limited liability company and converted to a Nevada corporation as RX Scripted, Inc. on December 5, 2007. On December 16, 2009, an amendment was filed with the State of Nevada to change the name to “MedCareers Group, Inc.” (the “Company” or “MedCareers”) and change the authorized capital of the Company. On November 5, 2010, the Company issued 24,000,000 shares of its common stock in exchange for 100% of Nurses Lounge, Inc. (“Nurses Lounge”), a Texas corporation. As a result of the share exchange, Nurses Lounge became the wholly-owned subsidiary of MedCareers. As a result, the shareholders of Nurses Lounge owned a majority of the voting stock of MedCareers. The transaction was accounted for as a reverse merger whereby Nurses Lounge was considered to be the accounting acquirer as its shareholders retained control of MedCareers after the exchange, although MedCareers is the legal parent company. The share exchange was treated as a recapitalization of MedCareers. As such, Nurses Lounge (and its historical financial statements) is the continuing entity for financial reporting purposes. The financial statements have been prepared as if MedCareers had always been the reporting company and, on the share exchange date, changed its name and reorganized its capital. The Company operates a website for nurses, nursing schools and nurses organizations which enables the respective entities to communicate more easily and efficiently with their members. | |
Significant Accounting Policies: | |
The Company’s management selects accounting principles generally accepted in the United States of America and adopts methods for their application. The application of accounting principles requires the estimating, matching and timing of revenue and expense. The accounting policies used conform to generally accepted accounting principles which have been consistently applied in the preparation of these financial statements. | |
The financial statements and notes are representations of the Company’s management which is responsible for their integrity and objectivity. Management further acknowledges that it is solely responsible for adopting sound accounting practices, establishing and maintaining a system of internal accounting control and preventing and detecting fraud. The Company's system of internal accounting control is designed to assure, among other items, that 1) recorded transactions are valid; 2) valid transactions are recorded; and 3) transactions are recorded in the proper period in a timely manner to produce financial statements which present fairly the financial condition, results of operations and cash flows of the Company for the respective periods being presented. | |
Basis of Presentation: | |
The Company prepares its financial statements on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States. | |
Principles of Consolidation: | |
The financial statements include the accounts of MedCareers Group, Inc. as well as Nurses Lounge, Inc. All significant inter-company transactions have been eliminated. All amounts are presented in U.S. Dollars unless otherwise stated. | |
Cash and Cash Equivalents: | |
The Company considers all highly liquid debt instruments with a maturity of three months or less to be cash equivalents. At times, cash balances may be in excess of the Federal Deposit Insurance Corporation (“FDIC”) insurance limits. The carrying amount approximates fair market value. | |
Fixed Assets: | |
Fixed assets are carried at cost. Depreciation is provided over each asset’s estimated useful life. Upon retirement and disposal, the asset cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the determination of the net income. Additions and significant improvements are capitalized and depreciated. | |
Advertising Costs: | |
The Company incurred no advertising costs for the periods ended October 31, 2014 and January 31, 2014. | |
Income Taxes: | |
Income from the corporation is taxed at regular corporate rates per the Internal Revenue Code. Although the Company has tax loss carry-forwards (see Note 7), there is uncertainty as to utilization prior to their expiration. Accordingly, the future income tax asset amounts have been fully reserved by a valuation allowance. | |
Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. | |
Use of Estimates: | |
In order to prepare financial statements in conformity with accounting principles generally accepted in the United States, management must make estimates, judgments and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based. | |
Fair Value of Financial Instruments: | |
Pursuant to ASC No. 820, “Fair Value Measurements and Disclosures”, the Company is required to estimate the fair value of all financial instruments included on its balance sheet as of January 31, 2014. The Company’s financial instruments consist of cash, accounts payable, advances and notes payable. The Company considers the carrying value of such amounts in the financial statements to approximate their fair value due to the short-term nature of these financial instruments. | |
Revenue Recognition: | |
Revenue from contracts for consulting services with fees based on time and materials or cost-plus are recognized as the services are performed and amounts are earned. The Company considers amounts to be earned once evidence of an arrangement has been obtained, services are delivered, fees are fixed or determinable, and collectability is reasonably assured. For contracts with fixed fees, the Company recognizes revenues as amounts become billable in accordance with contract terms, provided the billable amounts are not contingent, are consistent with the services delivered, and are earned. The Company recognizes revenue in accordance with ASC 605-10, "Revenue Recognition in Financial Statements", (formerly Staff Accounting Bulletin No. 104 (“SAB 104”)). Revenue is recognized when persuasive evidence of an arrangement exists, delivery or service has occurred, the sales price is fixed or determinable and receipt of payment is probable. | |
Earnings per Common Share: | |
Earnings (loss) per share are calculated in accordance with ASC 260 “Earnings per Share”. The weighted average number of common shares outstanding during each period is used to compute basic earnings (loss) per share. Diluted earnings per share are computed using the weighted average number of shares and potentially dilutive common shares outstanding. Dilutive potential common shares are additional common shares assumed to be exercised. Potentially dilutive common shares consist of stock options and are excluded from the diluted earnings per share computation in periods where the Company has incurred a net loss, as their effect would be considered anti-dilutive. | |
There were no potentially dilutive common stock equivalents as of October 31, 2014, therefore basic earnings per share equals diluted earnings per share for the period ended October 31, 2014. The Company had 17,743,000 options outstanding at October 31, 2014. As the Company incurred a net loss during the year ended October 31, 2014, the basic and diluted loss per common share is the same amount, as any common stock equivalents would be considered anti-dilutive. | |
Recently Issued Accounting Pronouncements: | |
The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flow. |
Significant_Accounting_Policie1
Significant Accounting Policies (Policies) | 9 Months Ended |
Oct. 31, 2014 | |
Accounting Policies [Abstract] | |
Basis of Presentation: | Basis of Presentation: |
The Company prepares its financial statements on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States. | |
Principles of Consolidation: | Principles of Consolidation: |
The financial statements include the accounts of MedCareers Group, Inc. as well as Nurses Lounge, Inc. All significant inter-company transactions have been eliminated. All amounts are presented in U.S. Dollars unless otherwise stated. | |
Cash and Cash Equivalents: | Cash and Cash Equivalents: |
The Company considers all highly liquid debt instruments with a maturity of three months or less to be cash equivalents. At times, cash balances may be in excess of the Federal Deposit Insurance Corporation (“FDIC”) insurance limits. The carrying amount approximates fair market value. | |
Fixed Assets: | Fixed Assets: |
Fixed assets are carried at cost. Depreciation is provided over each asset’s estimated useful life. Upon retirement and disposal, the asset cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the determination of the net income. Additions and significant improvements are capitalized and depreciated. | |
Advertising Costs: | Advertising Costs: |
The Company incurred no advertising costs for the periods ended October 31, 2014 and January 31, 2014. | |
Income Taxes: | Income Taxes: |
Income from the corporation is taxed at regular corporate rates per the Internal Revenue Code. Although the Company has tax loss carry-forwards (see Note 7), there is uncertainty as to utilization prior to their expiration. Accordingly, the future income tax asset amounts have been fully reserved by a valuation allowance. | |
Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. | |
Use of Estimates: | Use of Estimates: |
In order to prepare financial statements in conformity with accounting principles generally accepted in the United States, management must make estimates, judgments and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based. | |
Fair Value of Financial Instruments: | Fair Value of Financial Instruments: |
Pursuant to ASC No. 820, “Fair Value Measurements and Disclosures”, the Company is required to estimate the fair value of all financial instruments included on its balance sheet as of July 31, 2014. The Company’s financial instruments consist of cash, accounts payable, advances and notes payable. The Company considers the carrying value of such amounts in the financial statements to approximate their fair value due to the short-term nature of these financial instruments. | |
Revenue Recognition: | Revenue Recognition: |
Revenue from contracts for consulting services with fees based on time and materials or cost-plus are recognized as the services are performed and amounts are earned. The Company considers amounts to be earned once evidence of an arrangement has been obtained, services are delivered, fees are fixed or determinable, and collectability is reasonably assured. For contracts with fixed fees, the Company recognizes revenues as amounts become billable in accordance with contract terms, provided the billable amounts are not contingent, are consistent with the services delivered, and are earned. The Company recognizes revenue in accordance with ASC 605-10, "Revenue Recognition in Financial Statements", (formerly Staff Accounting Bulletin No. 104 (“SAB 104”)). Revenue is recognized when persuasive evidence of an arrangement exists, delivery or service has occurred, the sales price is fixed or determinable and receipt of payment is probable. | |
Earnings per Common Share: | Earnings per Common Share: |
Earnings (loss) per share are calculated in accordance with ASC 260 “Earnings per Share”. The weighted average number of common shares outstanding during each period is used to compute basic earnings (loss) per share. Diluted earnings per share are computed using the weighted average number of shares and potentially dilutive common shares outstanding. Dilutive potential common shares are additional common shares assumed to be exercised. Potentially dilutive common shares consist of stock options and are excluded from the diluted earnings per share computation in periods where the Company has incurred a net loss, as their effect would be considered anti-dilutive. | |
There were no potentially dilutive common stock equivalents as of October 31, 2014, therefore basic earnings per share equals diluted earnings per share for the period ended October 31, 2014. The Company had 17,743,000 options outstanding at October 31, 2014. As the Company incurred a net loss during the year ended October 31, 2014, the basic and diluted loss per common share is the same amount, as any common stock equivalents would be considered anti-dilutive. | |
Recently Issued Accounting Pronouncements: | Recently Issued Accounting Pronouncements: |
The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flow. |
Notes_Payable
Notes Payable | 9 Months Ended | |||||||
Oct. 31, 2014 | ||||||||
Debt Disclosure [Abstract] | ||||||||
Notes Payable | NOTE 2 - NOTES PAYABLE | |||||||
The components of the Company’s debt as of October 31, 2014 and January 31, 2013 were as follows: | ||||||||
Oct-14 | Jan-14 | |||||||
Note Payable - $100,000, 12% interest payable monthly or accrued, due Nov 4, 2013 | $100,000 | $100,000 | ||||||
Note Payable - $50,000, 12% interest payable monthly or accrued, due on demand | 50,000 | 50,000 | ||||||
Note Payable - $468,150, 12% interest payable monthly or accrued, due on demand | 418,150 | 263,150 | ||||||
Note Payable - $25,000, 12% interest added to note quarterly, due April 30, 2013 | 25,000 | 25,000 | ||||||
Note Payable - $16,000, 12% interest added to note quarterly, due January 31, 2014 | 16,000 | 16,000 | ||||||
Note Payable - $40,000, 20% interest added to note quarterly, due July 28, 2012 | 20,000 | 40,000 | ||||||
Note Payable - $4,000, 12% interest added to note quarterly, due April 30, 2013 | 4,000 | 4,000 | ||||||
Note Payable - $45,000, 12% interest added to note quarterly, due Nov 5, 2013 | 45,000 | 45,000 | ||||||
Note Payable - $5,000, 12% interest added to note quarterly, due Nov 5, 2013 | 5,000 | 5,000 | ||||||
Note Payable - $30,000, 8% interest, due Jan 31, 2014 | 30,000 | 30,000 | ||||||
Note Payable - $42,500, 8% interest, due May 15, 2014 | 8,500 | 32,500 | ||||||
Note Payable - $32,500, 8% interest, due Sept 20, 2014 | 32,500 | 0 | ||||||
Note Payable - $32,500, 8% interest, due Nov 21, 2014 | 32,500 | 0 | ||||||
Note Payable - $32,500, 8% interest, due Feb 7, 2014 | 32,500 | 0 | ||||||
Note Payable - $32,500, 8% interest, due Mar 15, 2014 | 32,500 | 0 | ||||||
Note Payable - $32,000, 8% interest, due Nov 21, 2014 | 32,000 | 0 | ||||||
Note Payable - $33,000, 8% interest, due Nov 23, 2014 | 33,000 | 0 | ||||||
Note Payable - $19,500, 8% interest, due on demand | 19,500 | 0 | ||||||
Note Payable - $72,500, 8% interest, due Jan 14, 2015 | 72,500 | 0 | ||||||
Note Payable - $72,500, 8% interest, due Jan 14, 2015 | 25,000 | 0 | ||||||
Subtotal | 1,033,650 | 610,650 | ||||||
Less – currently payable | -1,033,650 | -610,650 | ||||||
Long-term debt | $ | 0 | $ | 0 | ||||
The Company had accrued interest payable of $186,256 and $112,944 interest on the notes at October 31, 2014 and January 31, 2014, respectively. |
Stockholders_Equity
Stockholders Equity | 9 Months Ended | ||||
Oct. 31, 2014 | |||||
Equity [Abstract] | |||||
Stockholders Equity | NOTE 3 - STOCKHOLDERS’ EQUITY | ||||
Preferred Stock: | |||||
The Company is authorized to issue 10,000,000 shares of Preferred Stock, having a par value of $0.001 per share. There are no preferred shares outstanding at July 31, 2014 and January 31, 2014. | |||||
Common Stock: | |||||
The Company is authorized to issue 850,000,000 common shares at a par value of $0.001 per share. These shares have full voting rights. At October 31, 2014 and January 31, 2014, there were 83,210,142 and 65,715,368 shares outstanding, respectively. No dividends were paid in the periods ended October 31, 2014 or January 31, 2014. | |||||
Options and Warrants: | |||||
The Company had the following options or warrants outstanding at October 31, 2014: | |||||
Issued To | # Options | Dated | Expire | Strike Price | |
President and CEO | 4,000,000 | 11/18/10 | 11/18/16 | $0.10 per share | |
Vice President | 2,000,000 | 11/18/10 | 11/18/16 | $0.10 per share | |
Shareholder | 127,500 | 8/28/11 | 8/28/16 | $0.10 per share | |
Shareholder | 50,000 | 4/4/12 | 4/4/13 | $0.20 per share | |
Shareholder | 8,000 | 4/27/12 | 4/27/13 | $0.20 per share | |
Shareholder | 127,500 | 4/29/12 | 4/29/17 | $0.10 per share | |
Shareholder | 200,000 | 5/17/12 | 5/17/13 | $0.20 per share | |
Shareholder | 50,000 | 5/22/12 | 5/22/13 | $0.20 per share | |
Shareholder | 80,000 | 5/21/12 | 5/21/13 | $0.20 per share | |
Shareholder | 25,000 | 7/12/12 | 7/12/13 | $0.20 per share | |
Shareholder | 25,000 | 7/10/12 | 7/10/13 | $0.20 per share | |
Shareholder | 50,000 | 8/9/12 | 8/9/13 | $0.20 per share | |
Shareholder | 1,000,000 | 8/31/12 | 8/31/16 | $0.12 per share | |
Shareholder | 2,000,000 | 1/18/13 | 1/18/18 | $0.05 per share | |
Chief Financial Officer | 1,000,000 | 9/23/13 | 11/18/16 | $0.10 per share | |
Financier | 3,500,000 | 7/2/14 | 7/1/19 | $0.10 per share * | |
Chief Financial Officer | 1,000,000 | 7/31/14 | 7/31/17 | $0.10 per share | |
Salespersons | 2,500,000 | 7/31/14 | 1/31/18 | $0.10 per share | |
* The Company can redeem the option at $0.001 per share (total of $3,500) if the stock price closes above $0.125 for 15 consecutive days. |
Employee_Benefit_Plans
Employee Benefit Plans | 9 Months Ended |
Oct. 31, 2014 | |
Compensation and Retirement Disclosure [Abstract] | |
Employee Benefit Plans | NOTE 5 – EMPLOYEE BENEFIT PLANS |
During the periods ended October 31, 2014 and January 31, 2014, there were no qualified or non-qualified employee pension, profit sharing, stock option, or other plans authorized for any class of employees. |
Income_Taxes
Income Taxes | 9 Months Ended | ||||||||
Oct. 31, 2014 | |||||||||
Income Tax Disclosure [Abstract] | |||||||||
Income Taxes | NOTE 5 – INCOME TAXES | ||||||||
MedCareers Group, Inc. has incurred losses since inception. Therefore, MedCareers has no federal tax liability. Additionally, there are limitations imposed by certain transactions which are deemed to be ownership changes. The net deferred tax asset generated by the loss carryforward has been fully reserved. The cumulative net operating loss carryforward is about $6,358,682 at October 31, 2014 of which $5,521,482 is available for carryforward for federal income tax purposes and will expire in fiscal years 2026 to 2029. At October 31, 2014 and January 31, 2014, the deferred tax asset consisted of the following: | |||||||||
Oct-14 | Jan-14 | ||||||||
Deferred tax asset: | |||||||||
Net operating loss | $ | 1,840,776 | $ | 1,665,549 | |||||
Less valuation allowance | (1,840,776 | ) | (1,665,549 | ) | |||||
Net deferred tax asset | $ | 0 | $ | 0 | |||||
Commitments_and_Contingencies
Commitments and Contingencies | 9 Months Ended |
Oct. 31, 2014 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | NOTE 6 – COMMITMENTS AND CONTINGENCIES |
The Company may from time to time be involved with various litigation and claims that arise in the normal course of business. As of October 31, 2014, no such matters were outstanding. |
Going_Concern_and_Financial_Po
Going Concern and Financial Position | 9 Months Ended |
Oct. 31, 2014 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Going Concern and Financial Position | NOTE 7 - GOING CONCERN AND FINANCIAL POSITION |
MedCareers’ financial statements are prepared using United States generally accepted accounting principles applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has incurred cumulative losses through October 31, 2014 of $6,358,682 and has a working capital deficit at October 31, 2014 of $1,252,908. | |
Historically, revenues have not been sufficient to cover operating costs that would permit the Company to continue as a going concern. The potential proceeds from the sale of common stock and other contemplated debt and equity financing, and increases in operating revenues from new development and business acquisitions might enable MedCareers to continue as a going concern. There can be no assurance that the Company can or will be able to complete any debt or equity financing, or develop or acquire one or more business interests on terms favorable to it. MedCareers’ financial statements do not include any adjustments that might result from the outcome of this uncertainty. |
Recent_Accounting_Pronouncemen
Recent Accounting Pronouncements | 9 Months Ended |
Oct. 31, 2014 | |
Accounting Changes and Error Corrections [Abstract] | |
Recent Accounting Pronouncements | NOTE 9 – RECENT ACCOUNTING PRONOUNCEMENTS |
The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flows. |
Notes_Payable_Tables
Notes Payable (Tables) | 9 Months Ended | |||||||
Oct. 31, 2014 | ||||||||
Debt Disclosure [Abstract] | ||||||||
Notes Payable | ||||||||
Oct-14 | Jan-14 | |||||||
Note Payable - $100,000, 12% interest payable monthly or accrued, due Nov 4, 2013 | $100,000 | $100,000 | ||||||
Note Payable - $50,000, 12% interest payable monthly or accrued, due on demand | 50,000 | 50,000 | ||||||
Note Payable - $468,150, 12% interest payable monthly or accrued, due on demand | 418,150 | 263,150 | ||||||
Note Payable - $25,000, 12% interest added to note quarterly, due April 30, 2013 | 25,000 | 25,000 | ||||||
Note Payable - $16,000, 12% interest added to note quarterly, due January 31, 2014 | 16,000 | 16,000 | ||||||
Note Payable - $40,000, 20% interest added to note quarterly, due July 28, 2012 | 20,000 | 40,000 | ||||||
Note Payable - $4,000, 12% interest added to note quarterly, due April 30, 2013 | 4,000 | 4,000 | ||||||
Note Payable - $45,000, 12% interest added to note quarterly, due Nov 5, 2013 | 45,000 | 45,000 | ||||||
Note Payable - $5,000, 12% interest added to note quarterly, due Nov 5, 2013 | 5,000 | 5,000 | ||||||
Note Payable - $30,000, 8% interest, due Jan 31, 2014 | 30,000 | 30,000 | ||||||
Note Payable - $42,500, 8% interest, due May 15, 2014 | 8,500 | 32,500 | ||||||
Note Payable - $32,500, 8% interest, due Sept 20, 2014 | 32,500 | 0 | ||||||
Note Payable - $32,500, 8% interest, due Nov 21, 2014 | 32,500 | 0 | ||||||
Note Payable - $32,500, 8% interest, due Feb 7, 2014 | 32,500 | 0 | ||||||
Note Payable - $32,500, 8% interest, due Mar 15, 2014 | 32,500 | 0 | ||||||
Note Payable - $32,000, 8% interest, due Nov 21, 2014 | 32,000 | 0 | ||||||
Note Payable - $33,000, 8% interest, due Nov 23, 2014 | 33,000 | 0 | ||||||
Note Payable - $19,500, 8% interest, due on demand | 19,500 | 0 | ||||||
Note Payable - $72,500, 8% interest, due Jan 14, 2015 | 72,500 | 0 | ||||||
Note Payable - $72,500, 8% interest, due Jan 14, 2015 | 25,000 | 0 | ||||||
Subtotal | 1,033,650 | 610,650 | ||||||
Less – currently payable | -1,033,650 | -610,650 | ||||||
Long-term debt | $ | 0 | $ | 0 | ||||
Stockholders_Equity_Tables
Stockholders Equity (Tables) | 9 Months Ended | ||||
Oct. 31, 2014 | |||||
Equity [Abstract] | |||||
Stockholders Equity | Issued To | # Options | Dated | Expire | Strike Price |
President and CEO | 4,000,000 | 11/18/10 | 11/18/16 | $0.10 per share | |
Vice President | 2,000,000 | 11/18/10 | 11/18/16 | $0.10 per share | |
Shareholder | 127,500 | 8/28/11 | 8/28/16 | $0.10 per share | |
Shareholder | 50,000 | 4/4/12 | 4/4/13 | $0.20 per share | |
Shareholder | 8,000 | 4/27/12 | 4/27/13 | $0.20 per share | |
Shareholder | 127,500 | 4/29/12 | 4/29/17 | $0.10 per share | |
Shareholder | 200,000 | 5/17/12 | 5/17/13 | $0.20 per share | |
Shareholder | 50,000 | 5/22/12 | 5/22/13 | $0.20 per share | |
Shareholder | 80,000 | 5/21/12 | 5/21/13 | $0.20 per share | |
Shareholder | 25,000 | 7/12/12 | 7/12/13 | $0.20 per share | |
Shareholder | 25,000 | 7/10/12 | 7/10/13 | $0.20 per share | |
Shareholder | 50,000 | 8/9/12 | 8/9/13 | $0.20 per share | |
Shareholder | 1,000,000 | 8/31/12 | 8/31/16 | $0.12 per share | |
Shareholder | 2,000,000 | 1/18/13 | 1/18/18 | $0.05 per share | |
Chief Financial Officer | 1,000,000 | 9/23/13 | 11/18/16 | $0.10 per share | |
Financier | 3,500,000 | 7/2/14 | 7/1/19 | $0.10 per share * | |
Chief Financial Officer | 1,000,000 | 7/31/14 | 7/31/17 | $0.10 per share | |
Salespersons | 2,500,000 | 7/31/14 | 1/31/18 | $0.10 per share | |
*The Company can redeem the option at $0.001 per share (total of $3,500) if the stock price closes above $0.125 for 15 consecutive days. |
Income_Taxes_Tables
Income Taxes (Tables) | 9 Months Ended | ||||||||
Oct. 31, 2014 | |||||||||
Income Tax Disclosure [Abstract] | |||||||||
Deferred Tax Table | Oct-14 | Jan-14 | |||||||
Deferred tax asset: | |||||||||
Net operating loss | $ | 1,840,776 | $ | 1,665,549 | |||||
Less valuation allowance | (1,840,776 | ) | (1,665,549 | ) | |||||
Net deferred tax asset | $ | 0 | $ | 0 |
Income_Taxes_Deferred_Tax_Tabl
Income Taxes - Deferred Tax Table (Details) (USD $) | Oct. 31, 2014 | Jan. 31, 2014 |
Income Tax Disclosure [Abstract] | ||
Net operating loss | $1,840,276 | $1,665,549 |
Less valuation allowance | -1,840,276 | -1,665,549 |
Net deferred tax asset | $0 | $0 |
Notes_Payable_Details_Narrativ
Notes Payable (Details Narrative) (USD $) | Oct. 31, 2014 | Jan. 31, 2014 | Jan. 31, 2013 |
Debt Disclosure [Abstract] | |||
Accrued Interest Payable | $186,256 | $173,444 | $112,944 |
Stockholders_Equity_Details_Na
Stockholders Equity (Details Narrative) (USD $) | Oct. 31, 2014 | Jan. 31, 2014 |
Equity [Abstract] | ||
Common Stock, par value | $0.00 | $0.00 |
Common Stock, shares issued | 10,000,000 | 10,000,000 |
Common Stock, shares outstanding | 0 | 0 |
Preferred Stock, par value | $0.00 | $0.00 |
Preferred Stock, shares issued | 850,000,000 | 350,000,000 |
Preferred Stock, shares outstanding | 83,210,142 | 65,715,368 |
Income_Taxes_Details_Narrative
Income Taxes (Details Narrative) (USD $) | Oct. 31, 2014 |
Income Tax Disclosure [Abstract] | |
Cumulative Net Loss | $6,358,682 |